Diagnosis and treatment of BK virus-associated transplant nephropathy

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 213-227

  Vats, Abhay ^a   Randhawa, Parmjeet ^b   Shapiro, Ron ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BK VIRUS; BLOOD; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; PATHOLOGY; REVIEW; URINE; VIROLOGY; VIRUS INFECTION;

BK VIRUS; HUMANS; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS;

EID: 33745613028     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_16     Document Type: Review

References (76)

1. Shah K. Polyomaviruses. In: Fields B, Knipe D, Howley P, eds. Fields Virology. Philadelphia: Lippincott-Raven, 1996:2:2027-2043.
2. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784-787.
3. Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: Recent clinical facts and controversies. Transpl Infect Dis 2003: 5:65-71.
4. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611-623.
5. Baksh FK, Finkelstein SD, Swalsky PA et al. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 2001;38:354-365.
6. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000;342:1361-1363.
7. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12:599-605.
8. Ramos E, Vincenti F, Lu WX, et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77:131-133.
9. Gardner SD, MacKenzie EF, Smith C, et al. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37:578-586.
10. Li RM, Mannon RB, Kleiner D et al. BK virus and SV40 coinfection in polyomavirus nephropathy. Transplantation 2002; 74:1497-1504.
11. Trofe J, Gaber LW, Stratta RJ et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003; 5:21-28.
12. Binet I, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67:918-922.
13. Nickeleit V, Hirsch HH, Binet IF et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10:1080-1089.
14. Vats A, Shapiro R, Singh Randhawa P et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75:105-112.
15. Gardner SD, Field AM, Coleman DV et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1:1253-1257.
16. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488-496.
17. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13:2145-2151.
18. Haririan A, Ramos ER, Drachenberg CB et al. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73:1350-1353.
19. Etienne I, Francois A, Redonnet M et al. Does polyomavirus infection induce renal failure in cardiac transplant recipients? Transplant Proc 2000; 32:2794-2795.
20. Pappo O, Demetris AJ, Raikow RB et al. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9:105-109.
21. Nickeleit V, Hirsch HH, Zeiler M et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 1996;15:324-332.
22. Nickeleit V, Steiger J, Mihatsch MJ. BK virus infection after kidney transplantation. Graft 2002;5(Supplement December):S46-S57.
23. Buehrig CK, Lager DJ, Stegall MD et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64:665-673.
24. Celik B, Shapiro R, Vats A et al. Polyomavirus allograft nephropathy: Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 2003; 3:1378-1382.
25. Randhawa PS, Vats A, Week K et al. BK virus: Discovery, epidemiology, and biology. Graft 2002;5(Supplement December):S19-S27.
26. Mayr M, Nickeleit V, Hirsch HH et al. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis 2001; 38:E13.
27. Nickeleit V, Zeiler M, Gudat F et al. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13:242-251.
28. Ahuja M, Cohen EP, Dayer AM et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71:896-899.
29. Randhawa PS, Vats A, Zygmunt D et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74:485-488.
30. Li RM, Branton MH, Tanawattanacharoen S et al. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13:2320-2330.
31. Randhawa P, Baksh F, Aoki N et al. JC virus infection in allograft kidneys: Analysis by polymerase chain reaction and immunohistochemistry. Transplantation 2001; 71:1300-1303.
32. Boldorini R, Omodeo-Zorini E, Suno A et al. Molecular characterization and sequence analysis of polyomavirus strains isolated from needle biopsy specimens of kidney allograft recipients. Am J Clin Pathol 2001; 116:489-494.
33. Chang D, Wang M, Ou WC et al. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol 1996; 48:95-101.
34. Boldorini R, Zorini EO, Vigano P et al. Cytologic and biomolecular diagnosis of polyomavirus infection in urine specimens of HIV-positive patients. Acta Cytol 2000; 44:205-210.
35. Giri JA, Grcgoresky J, Silguero P et al. Polyoma virus JC DNA detection by polymerase chain reaction in CSF of HIV infected patients with suspected progressive multifocal leukoencephalopathy. Am Clin Lab 2001; 20:33-35.
36. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309-1315.
37. Drachenberg RC, Drachenberg CB, Papadimitriou JC et al. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant 2001; 1:373-381.
38. Scantlebury V, Randhawa P, Shapiro R et al. Cidofovir: A Method of Treatment for BK Virus-Associated Transplant Nephropathy. Graft 2002; 5(Supplement December):S82-S87.
39. Limaye AP, Jerome KR, Kuhr CS et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183:1669-1672.
40. Kadambi PV, Josephson MA, Williams J et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3:186-191.
41. Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: Experience at the university of Maryland renal transplant program. Clin Transpl 2002:143-153.
42. Ginevri F, De Santis R, Comoli P et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75:1266-1270
43. Ding R, Medeiros M, Dadhania D et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 2002; 74:987-994.
44. Kitamura T, Yogo Y, Kunitake T et al. Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients. Int J Urol 1994; 1:28-32.
45. Hirsch HH. Polyomavirus BK nephropathy: A (re)emerging complication in renal transplantation. Am J Transplant 2002; 2:25-30.
46. Lopez-Rocafort L, Wang C, Miller B et al. A prospective evaluation of BK virus infection in renal transplant patients, (abstract) Am J Transplant 2002; 2:S260.
47. Barri YM, Ahmad I, Ketel BL et al. Polyoma viral infection in renal transplantation: The role of immunosuppressive therapy. Clin Transplant 2001; 15:240-246.
48. Howell DN, Smith SR, Butterly DW et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68:1279-1288.
49. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184:1494-1495, author reply 1495-1496.
50. Hodur DM, Mandelbrot D. Immunosuppression and BKV Nephropathy. N Engl J Med 2002; 347:2079-2080, author reply 2079-2080.
51. Andrews CA, Shah KV, Daniel RW et al. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158:176-181
52. Priftakis P, Bogdanovic G, Tyden G et al. Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes. J CHn Microbiol 2000; 38:406-407.
53. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67:103-109.
54. Mengel M, Marwedel M, Radermacher J et al. Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18:1190-1196.
55. Randhawa P, Zygmunt D, Shapiro R et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int 2003; 64:743-747.
56. Swarup S, Randhawa P, Singla I et al. Cytokine gene polymorphism is associated with BK virus nephropathy in renal transplantation. J Am Soc Nephrol 2003; 12, [abstract].
57. Seabra C, Perez-Simon JA, Sierra M et al. Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26:1229-1230.
58. De Clercq E, Andrei G, Balzarini J et al. Antitumor potential of acyclic nucleoside phosphonates. Nucleosides Nucleotides 1999; 18:759-771.
59. Russell JK, Blalock JE. Vitamin A inhibition of polyoma virus replication. Biochem Biophys Res Commun 1984; 122:851-858.
60. Chen Y, Freund R, Listerud M et al. Retinoic acid inhibits transformation by preventing phosphatidylinositol 3-kinase dependent activation of the c-fos promoter. Oncogene 1999; 18:139-148.
61. Talmage DA, Listerud M. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene. Oncogene 1994; 9:3557-3563.
62. Portolani M, Pietrosemoli P, Cermelli C et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9:205-218.
63. Kerr DA, Chang CF, Gordon J et al. Inhibition of human neurotropic virus QCV) DNA replication in glial cells by camptothecin. Virology 1993; 196:612-618.
64. Vats A. Viral load monitoring in BK virus-associated nephropathy. Nephrol News Issues 2002; (Suppl):S17-19.
65. Lin PL, Vats AN, Green M. BK virus infection in renal transplant recipients. Pediatr Transplant 2001; 5:398-405.
66. Vats A, Shapiro R, Scantelbury V et al. BK Virus associated nephropathy and cidofovir: Long term experience. Am J Transplant 2003; 3 (Suppl 5):A190,[abstract].
67. . De Clercq E. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology 1997; 40:295-303.
68. De Clercq E. New inhibitors of human cytomegalovirus (HCMV) on the horizon. J Antimicrob Chemother 2003; 51:1079-1083.
69. Held TK, Biel SS, Nitsche A et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26:347-350.
70. Gonzalez-Fraile MI, Canizo C, Caballero D et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 2001; 3:44-46.
71. Poduval R, Kadambi P, Javaid B et al. Leflunomide: A potential new therapeutic agent for BK nephropathy [abstract]. Am J Transplant 2003; 3(Suppl 5):A189.
72. Foster P, Wright F, McLean D et al. Leflunomide administration as an adjunct in treatment of BK-polyoma viral disease in kidney allografts [abstract]. Am J Transplant 2003; 3(Suppl 5):A421.
73. Cibrik D, O'Toole J, Norman S et al. IVIG for the treatment of transplant BK nephropathy. Am J Transplant 2003; 3(Suppl 5):A370, [abstract].
74. Tata S, Milgrom M, Govani M et al. Novel strategy for the management of polyoma virus nephropathy [abstract]. Am J Transplant 2003; 3(Suppl 5).
75. Poduval RD, Meehan SM, Woodle ES et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 2002; 73:1166-1169.
76. Ginevri F, Pastorino N, de Santis R et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2003; 42:821-825.